Evidence-Based Medicine Guidelines
Short acting beta agonists for recurrent wheeze in children under 2 years of age
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Short Acting Beta Agonists for Recurrent Wheeze in Children Under 2 Years of Age." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/452215/all/Short_acting_beta_agonists_for_recurrent_wheeze_in_children_under_2_years_of_age.
Short acting beta agonists for recurrent wheeze in children under 2 years of age. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. https://evidence.unboundmedicine.com/evidence/view/EBMG/452215/all/Short_acting_beta_agonists_for_recurrent_wheeze_in_children_under_2_years_of_age. Accessed October 12, 2024.
Short acting beta agonists for recurrent wheeze in children under 2 years of age. (2019). In Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited. https://evidence.unboundmedicine.com/evidence/view/EBMG/452215/all/Short_acting_beta_agonists_for_recurrent_wheeze_in_children_under_2_years_of_age
Short Acting Beta Agonists for Recurrent Wheeze in Children Under 2 Years of Age [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. [cited 2024 October 12]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/452215/all/Short_acting_beta_agonists_for_recurrent_wheeze_in_children_under_2_years_of_age.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Short acting beta agonists for recurrent wheeze in children under 2 years of age
ID - 452215
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/452215/all/Short_acting_beta_agonists_for_recurrent_wheeze_in_children_under_2_years_of_age
PB - Duodecim Medical Publications Limited
DB - Evidence Central
DP - Unbound Medicine
ER -
